vs

Side-by-side financial comparison of Astrana Health, Inc. (ASTH) and Liberty Latin America Ltd. (LILA). Click either name above to swap in a different company.

Liberty Latin America Ltd. is the larger business by last-quarter revenue ($1.2B vs $950.5M, roughly 1.2× Astrana Health, Inc.). Astrana Health, Inc. runs the higher net margin — 0.7% vs -4.7%, a 5.4% gap on every dollar of revenue. On growth, Astrana Health, Inc. posted the faster year-over-year revenue change (42.9% vs 1.7%). Liberty Latin America Ltd. produced more free cash flow last quarter ($320.1M vs $-6.0M). Over the past eight quarters, Astrana Health, Inc.'s revenue compounded faster (53.3% CAGR vs 2.7%).

Astrana Health, Inc. is a U.S.-based value-based healthcare services provider that primarily serves Medicare-eligible senior populations across the United States. It offers in-home primary care, chronic disease management, and care coordination services, aiming to improve patient health outcomes and reduce unnecessary medical costs.

Liberty Global Ltd. is a British-Dutch-American multinational telecommunications company domiciled in Bermuda, with headquarters in London, Amsterdam and Denver. Its respective legal names are Liberty Global Holdings Limited (UK), Liberty Global B.V. (Netherlands) and Liberty Global, Inc., with the first of these being publicly traded. It was formed in 2005 by the merger of the international arm of Liberty Media and UnitedGlobalCom (UGC).

ASTH vs LILA — Head-to-Head

Bigger by revenue
LILA
LILA
1.2× larger
LILA
$1.2B
$950.5M
ASTH
Growing faster (revenue YoY)
ASTH
ASTH
+41.2% gap
ASTH
42.9%
1.7%
LILA
Higher net margin
ASTH
ASTH
5.4% more per $
ASTH
0.7%
-4.7%
LILA
More free cash flow
LILA
LILA
$326.1M more FCF
LILA
$320.1M
$-6.0M
ASTH
Faster 2-yr revenue CAGR
ASTH
ASTH
Annualised
ASTH
53.3%
2.7%
LILA

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ASTH
ASTH
LILA
LILA
Revenue
$950.5M
$1.2B
Net Profit
$6.6M
$-54.8M
Gross Margin
77.3%
Operating Margin
1.9%
10.8%
Net Margin
0.7%
-4.7%
Revenue YoY
42.9%
1.7%
Net Profit YoY
184.4%
74.0%
EPS (diluted)
$0.12
$-0.27

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ASTH
ASTH
LILA
LILA
Q4 25
$950.5M
$1.2B
Q3 25
$956.0M
$1.1B
Q2 25
$654.8M
$1.1B
Q1 25
$620.4M
$1.1B
Q4 24
$665.2M
$1.1B
Q3 24
$478.7M
$1.1B
Q2 24
$486.3M
$1.1B
Q1 24
$404.4M
$1.1B
Net Profit
ASTH
ASTH
LILA
LILA
Q4 25
$6.6M
$-54.8M
Q3 25
$373.0K
$3.3M
Q2 25
$9.4M
$-423.3M
Q1 25
$6.7M
$-136.4M
Q4 24
$-7.8M
$-210.4M
Q3 24
$16.1M
$-435.8M
Q2 24
$19.2M
$-42.7M
Q1 24
$14.8M
$-500.0K
Gross Margin
ASTH
ASTH
LILA
LILA
Q4 25
77.3%
Q3 25
77.7%
Q2 25
78.6%
Q1 25
78.5%
Q4 24
76.1%
Q3 24
78.7%
Q2 24
78.1%
Q1 24
78.2%
Operating Margin
ASTH
ASTH
LILA
LILA
Q4 25
1.9%
10.8%
Q3 25
2.0%
16.9%
Q2 25
3.1%
-30.6%
Q1 25
3.3%
11.8%
Q4 24
0.1%
8.7%
Q3 24
5.9%
-34.9%
Q2 24
6.2%
9.9%
Q1 24
7.5%
8.4%
Net Margin
ASTH
ASTH
LILA
LILA
Q4 25
0.7%
-4.7%
Q3 25
0.0%
0.3%
Q2 25
1.4%
-39.0%
Q1 25
1.1%
-12.6%
Q4 24
-1.2%
-18.5%
Q3 24
3.4%
-40.0%
Q2 24
3.9%
-3.8%
Q1 24
3.7%
-0.0%
EPS (diluted)
ASTH
ASTH
LILA
LILA
Q4 25
$0.12
$-0.27
Q3 25
$0.01
$0.02
Q2 25
$0.19
$-2.12
Q1 25
$0.14
$-0.69
Q4 24
$-0.14
$-1.03
Q3 24
$0.33
$-2.22
Q2 24
$0.40
$-0.22
Q1 24
$0.31
$0.00

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ASTH
ASTH
LILA
LILA
Cash + ST InvestmentsLiquidity on hand
$429.5M
$783.9M
Total DebtLower is stronger
$7.9B
Stockholders' EquityBook value
$779.3M
$555.6M
Total Assets
$2.2B
$12.2B
Debt / EquityLower = less leverage
14.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ASTH
ASTH
LILA
LILA
Q4 25
$429.5M
$783.9M
Q3 25
$463.4M
$596.7M
Q2 25
$342.1M
$514.4M
Q1 25
$260.9M
$575.5M
Q4 24
$290.8M
$654.3M
Q3 24
$350.3M
$588.6M
Q2 24
$327.7M
$598.6M
Q1 24
$337.3M
$668.5M
Total Debt
ASTH
ASTH
LILA
LILA
Q4 25
$7.9B
Q3 25
$7.8B
Q2 25
$7.6B
Q1 25
$7.6B
Q4 24
$7.6B
Q3 24
$7.6B
Q2 24
$7.6B
Q1 24
$7.6B
Stockholders' Equity
ASTH
ASTH
LILA
LILA
Q4 25
$779.3M
$555.6M
Q3 25
$775.5M
$628.9M
Q2 25
$765.5M
$608.4M
Q1 25
$745.4M
$1.0B
Q4 24
$712.7M
$1.1B
Q3 24
$704.6M
$1.2B
Q2 24
$678.9M
$1.7B
Q1 24
$653.5M
$1.7B
Total Assets
ASTH
ASTH
LILA
LILA
Q4 25
$2.2B
$12.2B
Q3 25
$2.2B
$12.0B
Q2 25
$1.4B
$12.0B
Q1 25
$1.3B
$12.6B
Q4 24
$1.4B
$12.8B
Q3 24
$1.3B
$12.7B
Q2 24
$1.3B
$13.2B
Q1 24
$1.2B
$13.3B
Debt / Equity
ASTH
ASTH
LILA
LILA
Q4 25
14.17×
Q3 25
12.45×
Q2 25
12.50×
Q1 25
7.47×
Q4 24
6.99×
Q3 24
6.20×
Q2 24
4.59×
Q1 24
4.38×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ASTH
ASTH
LILA
LILA
Operating Cash FlowLast quarter
$-2.9M
$461.9M
Free Cash FlowOCF − Capex
$-6.0M
$320.1M
FCF MarginFCF / Revenue
-0.6%
27.6%
Capex IntensityCapex / Revenue
0.3%
12.2%
Cash ConversionOCF / Net Profit
-0.44×
TTM Free Cash FlowTrailing 4 quarters
$104.5M
$305.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ASTH
ASTH
LILA
LILA
Q4 25
$-2.9M
$461.9M
Q3 25
$10.0M
$178.2M
Q2 25
$90.9M
$141.2M
Q1 25
$16.6M
$24.6M
Q4 24
$-10.9M
$398.6M
Q3 24
$34.0M
$177.5M
Q2 24
$23.2M
$156.9M
Q1 24
$6.0M
$23.3M
Free Cash Flow
ASTH
ASTH
LILA
LILA
Q4 25
$-6.0M
$320.1M
Q3 25
$7.4M
$56.0M
Q2 25
$89.5M
$1.9M
Q1 25
$13.6M
$-72.1M
Q4 24
$-13.5M
$234.9M
Q3 24
$31.7M
$51.0M
Q2 24
$20.4M
$16.4M
Q1 24
$5.6M
$-86.4M
FCF Margin
ASTH
ASTH
LILA
LILA
Q4 25
-0.6%
27.6%
Q3 25
0.8%
5.0%
Q2 25
13.7%
0.2%
Q1 25
2.2%
-6.7%
Q4 24
-2.0%
20.6%
Q3 24
6.6%
4.7%
Q2 24
4.2%
1.5%
Q1 24
1.4%
-7.9%
Capex Intensity
ASTH
ASTH
LILA
LILA
Q4 25
0.3%
12.2%
Q3 25
0.3%
11.0%
Q2 25
0.2%
12.8%
Q1 25
0.5%
8.9%
Q4 24
0.4%
14.4%
Q3 24
0.5%
11.6%
Q2 24
0.6%
12.6%
Q1 24
0.1%
10.0%
Cash Conversion
ASTH
ASTH
LILA
LILA
Q4 25
-0.44×
Q3 25
26.69×
54.00×
Q2 25
9.65×
Q1 25
2.48×
Q4 24
Q3 24
2.11×
Q2 24
1.21×
Q1 24
0.40×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ASTH
ASTH

Medicare$542.4M57%
Commercial$99.1M10%
Care Delivery$92.1M10%
Care Enablement$78.9M8%
Other Third Parties$58.0M6%
Health Care Patient Service$39.8M4%
Health Care Other$25.5M3%
Other$12.1M1%
Management Service$10.3M1%

LILA
LILA

Liberty Cablevisionof Puerto Rico LLC Liberty Puerto Rico$301.3M26%
Cable Wireless Communications Limited CW Panama$230.1M20%
Costa Rica Segment$168.2M15%
Liberty Networks$129.3M11%
Cable Subscription$112.4M10%
Mobile Subscription$95.9M8%
Mobile Handset And Other Devices$73.0M6%
Liberty Networks Other$25.0M2%
Mobile Non Subscription$21.6M2%
B2B Mobile Handsetand Other Devices$7.0M1%
Cable Non Subscription$4.3M0%

Related Comparisons